Samsung Gets European Approval for Enbrel Copy

Samsung Group said it has won approval from regulators to sell a near-replica of the blockbuster rheumatoid arthritis drug Enbrel in Europe.

from WSJ.com: US Business http://ift.tt/1UYpWqo
via IFTTT